Immunic
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Immunic and other ETFs, options, and stocks.About IMUX
Immunic, Inc. is a clinical-stage biopharmaceutical company, which develops a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases. It focuses on ulcerative colitis, Crohn’s disease, relapsing-remitting multiple sclerosis, and psoriasis.
CEODaniel Vitt
CEODaniel Vitt
Employees91
Employees91
HeadquartersNew York, New York
HeadquartersNew York, New York
Founded2003
Founded2003
Employees91
Employees91
IMUX Key Statistics
Market cap94.21M
Market cap94.21M
Price-Earnings ratio-0.98
Price-Earnings ratio-0.98
Dividend yield—
Dividend yield—
Average volume1.15M
Average volume1.15M
High today$0.964
High today$0.964
Low today$0.9303
Low today$0.9303
Open price$0.9493
Open price$0.9493
Volume1.10M
Volume1.10M
52 Week high$2.11
52 Week high$2.11
52 Week low$0.561
52 Week low$0.561
Analyst ratings
100%
of 6 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own IMUX. This list is generated using Robinhood data, and it’s not a recommendation.